Tributary Capital Management

Tributary Capital Management Small Cap Equity Strategy

Jun 2026 → Sep 2026

Our archive holds 2 letters from this strategy, behind 4 investment theses and positions in 29 companies. Every quote below is copied verbatim from the letter it came from.

2 letters in a year — follow all of Tributary Capital Management for every strategy.

Performance

as of Sep 30, 2026 · net of fees · USD

  • YTD
    +21.7%
    index +13.7%
  • 1Y
    +20.4%
    index +16.2%

Index: Russell 2000 Index

Disclaimer

These figures are copied from the manager’s latest letter, as of Sep 30, 2026. They were extracted automatically, have not been verified by HF Best Ideas and may contain errors. They cover a single share class, in the currency and fee basis stated above; other share classes and your own returns will differ. This is not investment advice, nor an offer to buy or sell any fund. Past performance does not predict future returns.

Read full disclosures →

What it bought and sold

  • ExitedEnovisSep 2026
    During the quarter, we exited our position in Enovis, a manufacturer of artificial joints, surgical implant tools and orthopedic braces.
  • New positionCavco IndustriesJun 2026
    During the quarter four new positions were added to the portfolio.
  • New positionAAR Corp.Jun 2026
    We initiated our position after the valuation declined on fears that AI would displace its business.

Also held

Its investment theses

Every letter